Evidence map›Paper›PMID 30588040›Full record

ArticleInfection and drug resistance2018

Risk factors and prognosis of complicated urinary tract infections caused by

Aina Gomila, J Carratalà, N Eliakim-Raz, E Shaw, I Wiegand, L Vallejo-Torres, A Gorostiza, J M Vigo, S Morris, M Stoddart and 10 more

Abstract read
In one paragraph

Article in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Prevalence and Antimicrobial Resistance ofInfectious disease reports · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Impact of Antimicrobial Resistance ofVeterinary sciences · 2025
    Review
  10. Article
  11. Case Report: Persistent drug-resistantFrontiers in transplantation · 2025
    Article
  12. Article
  13. Article
  14. Multidrug-resistantIDCases · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Aina GomilaDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Català de la Salut (ICS-HUB), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, agomilagrange@gmail.com.
J CarratalàDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Català de la Salut (ICS-HUB), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, agomilagrange@gmail.com.
N Eliakim-RazDepartment of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel.
E ShawDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Català de la Salut (ICS-HUB), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, agomilagrange@gmail.com.
I WiegandAiCuris Anti-infective Cures, Wuppertal, Germany.
L Vallejo-TorresUCL Department of Applied Health Research, University College London, London, UK.
A GorostizaInstitut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain, agomilagrange@gmail.com.
J M VigoInformatics Unit, Fundació Institut Català de Farmacologia, Barcelona, Spain.
S MorrisUCL Department of Applied Health Research, University College London, London, UK.
M StoddartDepartment of Medical Microbiology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
S GrierDepartment of Medical Microbiology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
C VankAiCuris Anti-infective Cures, Wuppertal, Germany.
N CuperusJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
L Van den HeuvelJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
C VuongAiCuris Anti-infective Cures, Wuppertal, Germany.
A MacGowanDepartment of Medical Microbiology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
L LeiboviciDepartment of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel.
I AddyAiCuris Anti-infective Cures, Wuppertal, Germany.
M PujolDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Català de la Salut (ICS-HUB), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, agomilagrange@gmail.com.
COMBACTE MAGNET WP5 RESCUING Study Group and Study Sites

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeComplicated urinary tract infections (cUTIs) are among the most frequent health-care-associated infections. In patients with cUTI,

methodsThis was a multinational, retrospective, observational study at 20 hospitals in south and southeastern Europe, Turkey, and Israel including consecutive patients with cUTI hospitalized between January 2013 and December 2014. A mixed-effect logistic regression model was performed to assess risk factors for

resultsOf 1,007 episodes of cUTI, 97 (9.6%) were due to

conclusionPatients with

Indexed as

complicated urinary tract infectionshealth care-associated infectionsmultidrug-resistancePseudomonas aeruginosa

Identifiers

PMID30588040
PMCPMC6302800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.